Evolution of the ablation region after magnetic resonance-guided high-intensity focused ultrasound ablation in a Vx2 tumor model

Investigative Radiology

Volumn 48, Issue 6, 2013, Pages 381-386

  Wijlemans, Joost W ^a   Deckers, Roel ^b   Van Den Bosch, Maurice A A J ^a   Seinstra, Beatrijs A ^a   Van Stralen, Marijn ^b   Van Diest, Paul J ^a   Moonen, Chrit T W ^b   Bartels, Lambertus W ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Image Science Institute   (Netherlands)

Author keywords

ablation techniques; high intensity focused ultrasound ablation; interventional MRI; interventional radiology; magnetic resonanceYguided interventional procedures

Indexed keywords

GADOBUTROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY TEMPERATURE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; EXPERIMENTAL RABBIT; FOLLOW UP; HIGH INTENSITY FOCUSED ULTRASOUND; HISTOLOGY; IMAGING SOFTWARE; MUSCLE TUMOR; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RELIABILITY; TISSUE NECROSIS; TUMOR MODEL; TUMOR REGRESSION; TUMOR VOLUME; ULTRASOUND TRANSDUCER;

EID: 84877579424     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e3182820257     Document Type: Article

References (37)

1. Lencioni R, Crocetti L. Local-regional treatment of hepatocellular carcinoma. Radiology. 2012;262:43-58.
2. Sofocleous CT, Sideras P, Petre EN, et al. Ablation for the management of pulmonary malignancies. AJR Am J Roentgenol. 2011;197:W581YW589.
3. Rosenthal D, Callstrom MR. Critical review and state of the art in interventional oncology: benign and metastatic disease involving bone. Radiology. 2012;262:765-780.
4. Bertot LC, Sato M, Tateishi R, et al. Mortality and complication rates of percutaneous ablative techniques for the treatment of liver tumors: a systematic review. Eur Radiol. 2011;21:2584-2596.
5. Lynn JG, Zwemer RL, Chick AJ. The biological application of focused ultrasonic waves. Science. 1942;96:119-120.
6. Solomon SB, Nicol TL, Chan DY, et al. Histologic evolution of high-intensity focused ultrasound in rabbit muscle. Invest Radiol. 2003;38:293-301.
7. Hynynen K, Darkazanli A, Unger E, et al. MRI-guided noninvasive ultrasound surgery. Med Phys. 1993;20:107-115.
8. Damianou C, Hynynen K. The effect of various physical parameters on the size and shape of necrosed tissue volume during ultrasound surgery. J Acoust Soc Am. 1994;95:1641-1649.
9. Hynynen K, Darkazanli A, Damianou CA, et al. The usefulness of a contrast agent and gradient-recalled acquisition in a steady-state imaging sequence for magnetic resonance imagingYguided noninvasive ultrasound surgery. Invest Radiol. 1994;29:897-903.
10. Sapareto SA, Dewey WC. Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Phys. 1984;10:787-800.
11. Chung AH, Jolesz FA, Hynynen K. Thermal dosimetry of a focused ultrasound beam in vivo by magnetic resonance imaging. Med Phys. 1999;26:2017-2026.
12. Nikfarjam M, Muralidharan V, Christophi C. Mechanisms of focal heat destruction of liver tumors. J Surg Res. 2005;127:208-223.
13. McDannold N, Tempany CM, Fennessy FM, et al. Uterine leiomyomas: MR imagingYbased thermometry and thermal dosimetry during focused ultrasound thermal ablation. Radiology. 2006;240:263-272.
14. McDannold NJ, King RL, Jolesz FA, et al. Usefulness of MR imagingYderived thermometry and dosimetry in determining the threshold for tissue damage induced by thermal surgery in rabbits. Radiology. 2000;216:517-523.
15. Kim YS, Lim HK, Kim JH, et al. Dynamic contrast-enhanced magnetic resonance imaging predicts immediate therapeutic response of magnetic resonanceY guided high-intensity focused ultrasound ablation of symptomatic uterine fibroids. Invest Radiol. 2011;46:639-647.
16. Voogt MJ, Trillaud H, Kim YS, et al. Volumetric feedback ablation of uterine fibroids using magnetic resonanceYguided high intensity focused ultrasound therapy. Eur Radiol. 2012;22:411-417.
17. Huisman M, van den Bosch MA. MR-guided high-intensity focused ultrasound for noninvasive cancer treatment. Cancer Imaging. 2011;11:S161YS166.
18. Zini C, Hipp E, Thomas S, et al. Ultrasoundand MR-guided focused ultrasound surgery for prostate cancer. World J Radiol. 2012;4:247-252.
19. Fennessy FM, Tempany CM. A review of magnetic resonance imagingYguided focused ultrasound surgery of uterine fibroids. Top Magn Reson Imaging. 2006;17:173-179.
20. Jolesz FA. MRI-guided focused ultrasound surgery. Annu Rev Med. 2009;60: 417-430.
21. Schmitz AC, Gianfelice D, Daniel BL, et al. Image-guided focused ultrasound ablation of breast cancer: current status, challenges, and future directions. Eur Radiol. 2008;18:1431-1441.
22. Wijlemans JW, Bartels LW, Deckers R, et al. Magnetic resonanceYguided highintensity focused ultrasound (MR-HIFU) ablation of liver tumours. Cancer Imaging. 2012;12:387-394.
23. Kidd JG, Rous P. A transplantable rabbit carcinoma originating in a virusinduced papilloma and containing the virus in masked or altered form. J Exp Med. 1940;71:813-838.
24. Enholm JK, Kohler MO, Quesson B, et al. Improved volumetric MR-HIFU ablation by robust binary feedback control. IEEE Trans Biomed Eng. 2010; 57:103-113.
25. Kohler MO, Mougenot C, Quesson B, et al. Volumetric HIFU ablation under 3D guidance of rapid MRI thermometry. Med Phys. 2009;36:3521-3535.
26. Ishihara Y, Calderon A, Watanabe H, et al. A precise and fast temperature mapping using water proton chemical shift. Magn Reson Med. 1995;34: 814-823.
27. Hindman JC. Proton resonance shift of water in gas and liquid states. J Chem Phys. 1966;44:4582-4892.
28. DewhirstMW, Viglianti BL, Lora-Michiels M, et al. Basic principles of thermal dosimetry and thermal thresholds for tissue damage from hyperthermia. Int J Hyperthermia. 2003;19:267-294.
29. Yarmolenko PS, Moon EJ, Landon C, et al. Thresholds for thermal damage to normal tissues: an update. Int J Hyperthermia. 2011;27:320-343.
30. Hazle JD, Stafford RJ, Price RE. Magnetic resonance imagingYguided focused ultrasound thermal therapy in experimental animal models: correlation of ablation volumes with pathology in rabbit muscle and VX2 tumors. J Magn Reson Imaging. 2002;15:185-194.
31. Ritter F, Boskamp T, Homeyer A, et al. Medical image analysis. IEEE Pulse. 2011;2:60-70.
32. Dromain C, de Baere T, Elias D, et al. Hepatic tumors treated with percutaneous radio-frequency ablation: CTand MR imaging follow-up. Radiology. 2002; 223:255-262.
33. Palussiere J, Salomir R, Le Bail B, et al. Feasibility of MR-guided focused ultrasound with real-time temperature mapping and continuous sonication for ablation of VX2 carcinoma in rabbit thigh. Magn Reson Med. 2003;49:89-98.
34. Nikfarjam M, Malcontenti-Wilson C, Christophi C. Focal hyperthermia produces progressive tumor necrosis independent of the initial thermal effects. J Gastrointest Surg. 2005;9:410-417.
35. Chen L, Bouley D, Yuh E, et al. Study of focused ultrasound tissue damage using MRI and histology. J Magn Reson Imaging. 1999;10:146-153.
36. Khiat A, Gianfelice D, Amara M, et al. Influence of post-treatment delay on the evaluation of the response to focused ultrasound surgery of breast cancer by dynamic contrast enhanced MRI. Br J Radiol. 2006;79:308-314.
37. Kreb DL, Bosscha K, Ernst MF, et al. Use of cytokeratin 8 immunohistochemistry for assessing cell death after radiofrequency ablation of breast cancers. Biotech Histochem. 2011;86:404-412.